GE HealthCare Technologies Inc. reaffirmed earnings guidance for the full year 2024. For the year, the company expected organic revenue growth of approximately 4% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
78.02 USD | -0.66% | -2.29% | +0.91% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.91% | 35.6B | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.10% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+19.95% | 30.31B |
- Stock Market
- Equities
- GEHC Stock
- News GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024